glutamic acid has been researched along with Berylliosis in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crawford, F; Dai, S; Falta, MT; Fontenot, AP; Kappler, JW; Mack, DG; Marrack, P; Murphy, GA | 1 |
Du Bois, R; Fontenot, AP; Lympany, P; Maier, LA; McGrath, DS; Newman, LS; Sato, H; Sawyer, RT; Silveira, L; Welsh, K; Wilcox, E | 1 |
Ensey, JS; Kreiss, K; McCanlies, EC; Schuler, CR; Weston, A | 1 |
Amicosante, M; Deubner, D; Saltini, C | 1 |
du Bois, RM; Maier, LA; Newman, LS; Sato, H; Silveira, L; Spagnolo, P; Welsh, KI | 1 |
Newman, LS | 1 |
Richeldi, L; Saltini, C; Sorrentino, R | 1 |
Maier, LA; Marrone, BL; Newman, LS; Petrovic, M; Tatum, OL; Wang, Z; White, PS | 1 |
Bartell, SM; Faustman, EM; Omenn, GS; Ponce, RA; Takaro, TK; Zerbe, RO | 1 |
du Bois, RM; Fiorillo, MT; Germain, C; Jones-Williams, W; Lechler, R; Lombardi, G; Saltini, C; Sorrentino, R; Uren, J | 1 |
Amicosante, M; Arroyo, J; Berretta, F; Colizzi, V; Lechler, R; Lombardi, G; Saltini, C; Sanarico, N | 1 |
duBois, R; Lympany, P; Maier, L; Martyny, J; McGrath, D; Mroz, M; Murphy, J; Newman, LS; Zhang, L | 1 |
12 other study(ies) available for glutamic acid and Berylliosis
Article | Year |
---|---|
Crystal structure of HLA-DP2 and implications for chronic beryllium disease.
Topics: Alleles; Animals; Berylliosis; CD4-Positive T-Lymphocytes; Chronic Disease; Crystallography, X-Ray; Glutamic Acid; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Lung Diseases; Mice; Models, Molecular; Peptides; Protein Binding; Protein Structure, Secondary | 2010 |
Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
Topics: Adult; Aged; Berylliosis; Beryllium; Case-Control Studies; Chronic Disease; Epitopes; Female; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Histocompatibility Antigens Class II; HLA Antigens; HLA-DP Antigens; HLA-DP beta-Chains; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; HLA-DRB3 Chains; HLA-DRB4 Chains; HLA-DRB5 Chains; Humans; Immunization; Male; Middle Aged; Polymorphism, Genetic; Severity of Illness Index | 2003 |
The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
Topics: Alleles; Berylliosis; Chronic Disease; Genotype; Glutamic Acid; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Polymorphism, Restriction Fragment Length; Seroepidemiologic Studies | 2004 |
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
Topics: Adult; Berylliosis; Beryllium; Female; Genetic Variation; Glutamic Acid; HLA-DP Antigens; Humans; Lymphocyte Activation; Male; T-Lymphocytes | 2005 |
BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
Topics: Alleles; Berylliosis; Butyrophilins; Female; Genetic Predisposition to Disease; Glutamic Acid; HLA-DP Antigens; HLA-DP beta-Chains; Homozygote; Humans; Male; Membrane Glycoproteins; Middle Aged; Polymorphism, Genetic; White People | 2007 |
To Be2+ or not to Be2+: immunogenetics and occupational exposure.
Topics: Antigen-Presenting Cells; Berylliosis; Beryllium; Female; Genes, MHC Class II; Genetic Markers; Glutamates; Glutamic Acid; HLA-DP Antigens; Humans; Male; Occupational Exposure; Risk Factors; T-Lymphocytes, Helper-Inducer | 1993 |
HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
Topics: Adult; Alleles; Amino Acid Sequence; Base Sequence; Berylliosis; Beryllium; Disease Susceptibility; Female; Genes, MHC Class II; Genotype; Glutamates; Glutamic Acid; HLA-DP Antigens; Humans; Linkage Disequilibrium; Male; Middle Aged; Molecular Sequence Data; Occupational Exposure; Phenotype; Risk Factors | 1993 |
Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
Topics: Alleles; Berylliosis; Chronic Disease; Dimerization; Gene Frequency; Genetic Carrier Screening; Genetic Predisposition to Disease; Glutamic Acid; HLA-DP alpha-Chains; HLA-DP Antigens; HLA-DP beta-Chains; Homozygote; Humans | 1999 |
Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention.
Topics: Berylliosis; Chronic Disease; Cohort Studies; Cost of Illness; Environmental Exposure; Ethics, Medical; Forecasting; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Glutamic Acid; Health Expenditures; HLA-DP Antigens; Humans; Jurisprudence; Lysine; Occupational Exposure; Polymorphism, Genetic; Prevalence; Probability; Risk Assessment; Risk Management; Sensitivity and Specificity; Social Values | 2000 |
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
Topics: Alleles; Amino Acid Substitution; Animals; Berylliosis; Beryllium; Cell Culture Techniques; Cell Line, Transformed; Chronic Disease; Clone Cells; Cytokines; Epitopes, T-Lymphocyte; Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Genetic Predisposition to Disease; Glutamic Acid; HLA-DP Antigens; Humans; Male; Mice; T-Lymphocyte Subsets; Th1 Cells; Transfection | 2001 |
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Berylliosis; Beryllium; Biomarkers; Cell Line; Drosophila melanogaster; Genetic Predisposition to Disease; Genetic Vectors; Glutamic Acid; HLA-DP Antigens; Humans; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Solubility | 2001 |
Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
Topics: Berylliosis; Beryllium; Case-Control Studies; Chronic Disease; Genetic Markers; Genetic Predisposition to Disease; Glutamic Acid; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Logistic Models; Occupational Exposure; Respiratory Hypersensitivity; Risk Factors; Smoking | 2002 |